“The apprehension with applying non IID listed ingredients is justified as it is actually unattainable To judge if FDA would find the ‘novel excipient’ Harmless for use in the drug product as there is no described system for analysis and approval of excipients. The FDA guidance on ‘Nonclinical Scientific https://anciusi284ari0.ltfblog.com/profile